Company to send 12 million doses of COVID-19 vaccine adapted to target Omicron.
Moderna is supplying Canada with 12 million COVID-19 shots specifically designed to target the Omicron variant of COVID-19.
Last year, the Canadian government entered into a supply deal with the company for supply of its COVID vaccine for 2022 and 2023.
The contract does allow for access to new adaptations of the vaccine.
Moderna and Canada have agreed to convert six million doses of the company's COVID vaccine, which targets the original virus, to an Omicron-containing bivalent one.
The country will also purchase an addition 4.5 million doses of the Omicron-targeted shot, and is moving forward with a scheduled delivery of 1.5 million shots of the bivalent vaccine.
While existing COVID-19 inoculations continue to provide protections against hospitalization and death, experts say the effectiveness of the vaccine has decreased as the virus has evolved.
Chief Public Health Officer Dr. Theresa Tam says Health Canada is still reviewing submissions for bivalent vaccines from Moderna and Pfizer.

Trevor Birtch Trial Daily Recap - Case 2
Donations Open for Lights of Love
Stunt Drivers Busted in Oxford County
Federal Budget Survives Confidence Vote
Oxford OPP Lay Charges after Collision
Interview with Mayor Jerry Acchione - Nov. 17th 2025
News Poll: Winter Tires for Winter Driving
PJHL Recap - Nov 12th to Nov 16th
Tim Hortons Holiday Smile Cookie Week Begins!
Snow Squall Warning for Oxford County
Woodstonian Charged in Norwich Ave Disturbance
London Resident Killed in Zorra Crash
Woodstonian Charged in Zorra Township
New Program Launched at AHI and TDMH
Tree of Lights Returning to Ingersoll
Alexandra Hospital Receives $100,000 from ICF
Witnesses Wanted in Crash Investigation
Christmas Parade Hits Ingersoll Tomorrow
Woodstock Man Charged in Brant County
New Offices Coming to TVDSB
Comments
Add a comment